INSP Inspire Medical Systems Inc
Price (delayed)
$159.56
Market cap
$4.73B
P/E Ratio
88.64
Dividend/share
N/A
EPS
$1.8
Enterprise value
$4.61B
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the
Highlights
The net income has soared by 62% from the previous quarter
INSP's EPS has surged by 61% since the previous quarter
INSP's debt is up by 21% YoY and by 19% QoQ
The company's quick ratio fell by 14% YoY and by 10% QoQ
Key stats
What are the main financial stats of INSP
Market
Valuations
Earnings
Shares outstanding
29.67M
Market cap
$4.73B
Enterprise value
$4.61B
Price to earnings (P/E)
88.64
Price to book (P/B)
6.93
Price to sales (P/S)
5.92
EV/EBIT
78.9
EV/EBITDA
70.96
EV/Sales
5.75
Revenue
$802.8M
Gross profit
$679.82M
Operating income
$36.08M
Net income
$53.51M
EBIT
$58.48M
EBITDA
$65.03M
Free cash flow
$91.12M
Per share
Balance sheet
Liquidity
EPS
$1.8
EPS diluted
$1.75
Free cash flow per share
$3.06
Book value per share
$23.02
Revenue per share
$26.97
TBVPS
$27.16
Total assets
$808.38M
Total liabilities
$118.69M
Debt
$30.04M
Equity
$689.7M
Working capital
$542.31M
Debt to equity
0.04
Current ratio
7.13
Quick ratio
6.09
Net debt/EBITDA
-1.85
Margins
Efficiency
Dividend
EBITDA margin
8.1%
Gross margin
84.7%
Net margin
6.7%
Operating margin
4.5%
Return on assets
7.1%
Return on equity
8.2%
Return on invested capital
10.8%
Return on capital employed
8.1%
Return on sales
7.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INSP stock price
How has the Inspire Medical Systems stock price performed over time
Intraday
1%
1 week
-2.22%
1 month
-14.03%
1 year
-22.19%
YTD
-13.93%
QTD
0.18%
Financial performance
How have Inspire Medical Systems's revenue and profit performed over time
Revenue
$802.8M
Gross profit
$679.82M
Operating income
$36.08M
Net income
$53.51M
Gross margin
84.7%
Net margin
6.7%
The operating income has soared by 190% year-on-year and by 167% since the previous quarter
The operating margin has soared by 170% YoY and by 150% from the previous quarter
The net income has soared by 62% from the previous quarter
INSP's net margin has soared by 52% QoQ
Growth
What is Inspire Medical Systems's growth rate over time
Valuation
What is Inspire Medical Systems stock price valuation
P/E
88.64
P/B
6.93
P/S
5.92
EV/EBIT
78.9
EV/EBITDA
70.96
EV/Sales
5.75
INSP's EPS has surged by 61% since the previous quarter
The P/B is 59% below the 5-year quarterly average of 16.7 and 19% below the last 4 quarters average of 8.5
The company's equity rose by 20% YoY
The stock's P/S is 72% less than its 5-year quarterly average of 20.8 and 23% less than its last 4 quarters average of 7.6
Inspire Medical Systems's revenue has increased by 28% YoY and by 6% from the previous quarter
Efficiency
How efficient is Inspire Medical Systems business performance
INSP's ROE has soared by 55% since the previous quarter
INSP's ROA has soared by 54% from the previous quarter
INSP's return on sales is up by 49% since the previous quarter
INSP's ROIC is up by 46% from the previous quarter
Dividends
What is INSP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INSP.
Financial health
How did Inspire Medical Systems financials performed over time
The total liabilities is up by 19% from the previous quarter and by 14% YoY
The company's total assets rose by 19% YoY
INSP's debt is 96% lower than its equity
INSP's debt is up by 21% YoY and by 19% QoQ
The company's equity rose by 20% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.